Literature DB >> 28154170

Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway.

Liu-Ya Tang1, Mary Heller1, Zhaojing Meng2, Li-Rong Yu2, Yi Tang1, Ming Zhou2, Ying E Zhang3.   

Abstract

Transforming growth factor-β (TGF-β) signals through both SMAD and non-SMAD pathways to elicit a wide array of biological effects. Existing data have shown the association and coordination between STATs and SMADs in mediating TGF-β functions in hepatic cells, but it is not clear how STATs are activated under these circumstances. Here, we report that JAK1 is a constitutive TGFβRI binding protein and is absolutely required for phosphorylation of STATs in a SMAD-independent manner within minutes of TGF-β stimulation. Following the activation of SMADs, TGF-β also induces a second phase of STAT phosphorylation that requires SMADs, de novo protein synthesis, and contribution from JAK1. Our global gene expression profiling indicates that the non-SMAD JAK1/STAT pathway is essential for the expression of a subset of TGF-β target genes in hepatic stellate cells, and the cooperation between the JAK1-STAT3 and SMAD pathways is critical to the roles of TGF-β in liver fibrosis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Janus kinase (JAK); Liver fibrosis; SMAD transcription factor; STAT3; Smad3; hepatic stellate cell (HSC); transforming growth factor beta (TGF-B)

Mesh:

Substances:

Year:  2017        PMID: 28154170      PMCID: PMC5354477          DOI: 10.1074/jbc.M116.773085

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  The Jak/STAT pathway.

Authors:  Douglas A Harrison
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

2.  Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.

Authors:  Yan Liu; Heng Liu; Christoph Meyer; Jun Li; Silvio Nadalin; Alfred Königsrainer; Honglei Weng; Steven Dooley; Peter ten Dijke
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

3.  Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.

Authors:  Fanli Meng; Kai Wang; Tomonori Aoyama; Sergei I Grivennikov; YongHan Paik; David Scholten; Min Cong; Keiko Iwaisako; Xiao Liu; Mingjun Zhang; Christoph H Österreicher; Felix Stickel; Klaus Ley; David A Brenner; Tatiana Kisseleva
Journal:  Gastroenterology       Date:  2012-06-08       Impact factor: 22.682

4.  Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.

Authors:  Markus Mair; Gernot Zollner; Doris Schneller; Monica Musteanu; Peter Fickert; Judith Gumhold; Christian Schuster; Andrea Fuchsbichler; Martin Bilban; Stefanie Tauber; Harald Esterbauer; Lukas Kenner; Valeria Poli; Leander Blaas; Jan Wilhelm Kornfeld; Emilio Casanova; Wolfgang Mikulits; Michael Trauner; Robert Eferl
Journal:  Gastroenterology       Date:  2010-02-26       Impact factor: 22.682

5.  Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction.

Authors:  P Coffer; C Lutticken; A van Puijenbroek; M Klop-de Jonge; F Horn; W Kruijer
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

Review 6.  TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.

Authors:  Masato Morikawa; Rik Derynck; Kohei Miyazono
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-05-02       Impact factor: 10.005

Review 7.  TGF-β signalling and liver disease.

Authors:  Isabel Fabregat; Joaquim Moreno-Càceres; Aránzazu Sánchez; Steven Dooley; Bedair Dewidar; Gianluigi Giannelli; Peter Ten Dijke
Journal:  FEBS J       Date:  2016-02-22       Impact factor: 5.542

8.  The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Authors:  Alessandro Sorrentino; Noopur Thakur; Susanne Grimsby; Anders Marcusson; Verena von Bulow; Norbert Schuster; Shouting Zhang; Carl-Henrik Heldin; Maréne Landström
Journal:  Nat Cell Biol       Date:  2008-08-31       Impact factor: 28.824

9.  Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.

Authors:  Yi Tang; Krit Kitisin; Wilma Jogunoori; Cuiling Li; Chu-Xia Deng; Susette C Mueller; Habtom W Ressom; Asif Rashid; Aiwu Ruth He; Jonathan S Mendelson; John M Jessup; Kirti Shetty; Michael Zasloff; Bibhuti Mishra; E P Reddy; Lynt Johnson; Lopa Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

10.  Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.

Authors:  Mariko Kusaba; Kazuhiko Nakao; Takashi Goto; Daisuke Nishimura; Hiroshi Kawashimo; Hidetaka Shibata; Yasuhide Motoyoshi; Naota Taura; Tatsuki Ichikawa; Keisuke Hamasaki; Katsumi Eguchi
Journal:  J Hepatol       Date:  2007-06-06       Impact factor: 25.083

View more
  68 in total

1.  S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3/SMAD3 pathway.

Authors:  Zhiqiang Gong; Huisheng Ye; Yu Huo; Lei Wang; Yanhong Huang; Min Huang; Xingxing Yuan
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

3.  Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Sutapa Sarkar; Diana Kimono; Muayad Albadrani; Varun Chandrashekaran; Firas Al Hasson; Udai P Singh; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Eur J Pharmacol       Date:  2018-09-05       Impact factor: 4.432

Review 4.  Mechanistic insight into contextual TGF-β signaling.

Authors:  Ying E Zhang
Journal:  Curr Opin Cell Biol       Date:  2017-11-14       Impact factor: 8.382

Review 5.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

6.  Targeting myosin 1c inhibits murine hepatic fibrogenesis.

Authors:  Ehtesham Arif; Cindy Wang; Marzena K Swiderska-Syn; Ashish K Solanki; Bushra Rahman; Paul P Manka; Jason D Coombes; Ali Canbay; Salvatore Papa; Deepak Nihalani; Patricia Aspichueta; Joshua H Lipschutz; Wing-Kin Syn
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-04-28       Impact factor: 4.052

7.  STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and STAT3/STAT5 Disease Variants Modulate These Outcomes.

Authors:  Matija Hedl; Rui Sun; Chen Huang; Clara Abraham
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

8.  Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.

Authors:  Shoujun Gu; Sobia Zaidi; Md Imtaiyaz Hassan; Taj Mohammad; Tathiane M Malta; Houtan Noushmehr; Bryan Nguyen; Keith A Crandall; Jigisha Srivastav; Vincent Obias; Paul Lin; Bao-Ngoc Nguyen; Michael Yao; Ren Yao; Charles Hadley King; Raja Mazumder; Bibhuti Mishra; Shuyun Rao; Lopa Mishra
Journal:  Gastroenterology       Date:  2019-10-01       Impact factor: 22.682

9.  A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.

Authors:  Jinqiang Zhang; Chang Han; Nathan Ungerleider; Weina Chen; Kyoungsub Song; Ying Wang; Hyunjoo Kwon; Wenbo Ma; Tong Wu
Journal:  Hepatology       Date:  2018-12-31       Impact factor: 17.425

10.  BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways.

Authors:  Xiuxia Qu; Ying Liu; Dayan Cao; Jinghai Chen; Zhuo Liu; Hongrui Ji; Yuwen Chen; Wenjun Zhang; Ping Zhu; Deyong Xiao; Xiaohui Li; Weinian Shou; Hanying Chen
Journal:  J Biol Chem       Date:  2019-11-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.